COO/CFO Operations and Finance
Tom brings more than 30 years of financial and operational experience to GSS, with a track record of driving profitable revenue growth through organic and acquisition-based expansion. Tom served as Senior Vice President of Quintiles Clinical Operations and SVP of Quintiles Central Labs delivering strategic leadership to global clinical operations businesses. Quintiles’ global laboratory business grew from ~$50M to ~$400M during Tom’s tenure and included roughly 1,900 employees and laboratories in the US, Europe, Asia, Latin America and Africa. Prior to SVP roles, Tom served as CFO for Quintiles Laboratories and for two publicly traded companies. Tom received his BA in Economics from Dickinson College and his MBA in accounting from Rutgers.
Chief Technology Officer
Pete brings GSS more than 30 years of business solution engineering expertise across all major application facets – vendor, employee and customer. Pete has provided strategic analysis and leadership from implementation through service assurance delivering fully integrated business solutions in healthcare and manufacturing sectors. Before joining GSS, Pete spent two years at Medfusion as VP of IT, developing and delivering an IT strategy to meet the organization’s desire to be a molecular center of excellence. Prior to Medfusion, Pete worked for approximately 10 years in various technical and managerial roles at Quintiles, from enterprise architect to business line product manager. Before Quintiles, Pete’s career included an entrepreneurial stint and roles at GE Healthcare and MDS. Pete holds a BSc in Software Engineering from University College of Wales, Aberystwyth, and he completed the Executive Program from Queen’s University School of Business in Kingston, Ontario.
SVP, Corporate Strategy and Business Development
Tom brings GSS more than 30 years of business development, strategy and marketing experience across all the major touchpoints – vendor, employee and customer. Tom’s work in the IT, food technology and regulatory fields provides GSS with a unique and objective perspective on business strategies, partnerships and customer-focused innovation. Before joining GSS, Tom was Executive Vice President of SinnovaTek, where he directed the marketing of their innovative processing solutions and expertise to leading food & beverage companies. Prior to SinnovaTek, Tom was CEO of Alrgn Bio, where he led the overall management of the company and the commercialization of their patented process that removes harmful allergens from peanuts. Tom previously held leadership business development, partnership, strategy and marketing roles at IBM, Lenovo, Ocean Spray and several smaller IT and food technology companies and has directed the development and market introduction of numerous breakthrough products and technologies. Tom earned his MBA from UNC-Chapel Hill Kenan-Flagler Business School and his undergraduate degree at Vanderbilt University in Engineering Science.
|L. Scott Clark
VP, Global Quality Assurance
L. Scott Clark received his Ph.D. in Cell and Molecular Biology from the University of Vermont. After his post-doctoral fellowship with the University of North Carolina-Chapel Hill and the EPA, Scott started his career in regulated research and clinical contract work. Scott had over 18 years of experience in genetic toxicology, pharmacogenomics and genetics. He has held several executive roles including Research and Development, Clinical Operations, Scientific Affairs, and Global Quality Assurance. Dr. Clark also is an Adjunct Assistant Professor at UNCCH in the Division of Pharmacotherapy and Experimental Therapeutics. Scott is now bringing his quality assurance, scientific, and business experience to Global Specimen Solutions to enable clients to maximize their specimens for current and future biomedical research.
VP, Client Operations and Scientific Data Strategy
Kate comes to GSS from Merck Pharmaceuticals where she served as the primary clinical scientific data strategist to integrate genetic, pharmacogenomics, and biomarker data into clinical trials. Her expertise spans project management, IT, scientific knowledge, vendor management, and business strategy. Kate has over 17 years of industry and academic experience in research-based sample management. Her focus has been on creating innovative integrative solutions to enable in-life actionable decisions to drive commercial success and advance pipeline management for precision medicine and genomic-based drug discovery and development. Kate is now bringing her expertise to champion client business strategies and to help continue improving translational science through powerful new pipeline data management analytics. Kate holds a BS in Biology from Widener University and a MS in Molecular Pharmacology from Thomas Jefferson University, and she completed the Project Management Leadership Group Program and seeks a PhD in Epidemiology.